An initial assessment of CCR7 expression in cystectomy sections by immunohistochemistry of 119 patients found that CCR7 was overexpressed in 24% of urothelial cancers of the bladder; however, CCR7 was not associated with an aggressive form of cancer [86]. Here, CCR7 is linked to bladder transitional cell carcinoma.